Tesa Labtec Gmbh competitive analysis

Explore patent oppositions filed by Tesa Labtec Gmbh against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 8, 2026
Patent NumberTitleApplicantOpposition Date
Sustained Analgesia Achieved With Transdermal Delivery Of BuprenorphineEURO CELTIQUEDec 20, 2017

Explore Tesa Labtec Gmbh's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 8, 2026
Patent NumberPublication DateTitleTotal Oppositions
Mar 9, 2016Method For Producing And Monitoring Oral Active Ingredient Films1

Latest PTAB cases involving Tesa Labtec Gmbh

Discover the latest PTAB cases involving Tesa Labtec Gmbh, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Tesa Labtec Gmbh with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 8, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TESA LABTEC GMBH11 - -
EURO CELTIQUE - 73 - -
LTS LOHMANN THERAPIE SYSTEME1315 - -
MUNDIPHARMA235 - -